Cretostimogene Grenadanorepvec

· CG Oncology, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Cretostimogene Grenadanorepvec, covering 2026-01-12 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

See pricing